Aberrant histone methylation and acetylation, ATRX mutations impacting chromatin stability, and widespread promoter hypermethylation, including MGMT, disrupt the balance between tumor suppressor genes and oncogenic pathways. This evidence concerns the gene MGMT and neoplasm.